5j31 image
Deposition Date 2016-03-30
Release Date 2016-10-19
Last Version Date 2024-11-20
Entry Detail
PDB ID:
5J31
Title:
Crystal structure of 14-3-3zeta in complex with an alkyne cross-linked cyclic peptide derived from ExoS
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.21
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:14-3-3 protein zeta/delta
Gene (Uniprot):YWHAZ
Chain IDs:A, B
Chain Length:230
Number of Molecules:2
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Exoenzyme S
Gene (Uniprot):exoS
Chain IDs:C, D
Chain Length:10
Number of Molecules:2
Biological Source:Pseudomonas aeruginosa
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
MK8 C LEU modified residue
Ligand Molecules
Primary Citation
Constraining an Irregular Peptide Secondary Structure through Ring-Closing Alkyne Metathesis.
Chembiochem 17 1915 1919 (2016)
PMID: 27596722 DOI: 10.1002/cbic.201600362

Abstact

Macrocyclization can be used to constrain peptides in their bioactive conformations, thereby supporting target affinity and bioactivity. In particular, for the targeting of challenging protein-protein interactions, macrocyclic peptides have proven to be very useful. Available approaches focus on the stabilization of α-helices, which limits their general applicability. Here we report for the first time on the use of ring-closing alkyne metathesis for the stabilization of an irregular peptide secondary structure. A small library of alkyne-crosslinked peptides provided a number of derivatives with improved target affinity relative to the linear parent peptide. In addition, we report the crystal structure of the highest-affinity derivative in a complex with its protein target 14-3-3ζ. It can be expected that the alkyne-based macrocyclization of irregular binding epitopes should give rise to new scaffolds suitable for targeting of currently intractable proteins.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback